DentalWig PLUS™ – Diabetes

Description

MYDENTALWIG’s First Planned EI²™-Powered Product

Expected starting price: $4,999 for 1 jaw – Expected pre-orders: Fall 2027

Transforming dental technology into a new sensory layer of human metabolism.

MYDENTALWIG is developing DentalWig PLUS™ – Diabetes, an advanced dental replacement concept designed to integrate intraoral sensing technology with Artificial Intelligence (AI) and physiological data to create a new approach to understanding eating behavior and metabolic health.

Built on MYDENTALWIG’s dental technology foundation, DentalWig PLUS™ represents the first planned product in the Company’s EI²™ (Enhanced Ingestion Intelligence) ecosystem, designed to connect what people eat, how they eat, and when they eat with how their bodies respond.

The Missing Link in Metabolic Health

Today’s healthcare technologies can measure many aspects of human physiology, including heart rate, physical activity, and continuous glucose levels. Yet objectively measuring ingestion behavior and connecting it with an individual’s physiological response remains a significant technological challenge.

DentalWig PLUS™ is being developed to address this gap by combining an intraoral dental sensor with AI-powered Ingestion Intelligence™.

The objective is to create a system capable of detecting and characterizing eating events, learning individual ingestion patterns, and correlating those patterns with physiological responses—including glucose fluctuations captured through continuous glucose monitoring (CGM).

How DentalWig PLUS™ Is Designed to Work

1. Intraoral Ingestion Sensing

An embedded dental sensing system designed to detect chewing patterns, bite activity, and the timing of ingestion events.

2. Physiological Data Integration

Integration with compatible continuous glucose monitors and, where appropriate, contextual data such as sleep, physical activity, and other relevant physiological indicators.

3. EI²™ Artificial Intelligence

Proprietary AI models designed to identify eating patterns, analyze relationships between ingestion behavior and glucose responses, and learn individualized metabolic response profiles.

4. Personalized Metabolic Intelligence

The long-term objective is to develop predictive capabilities that could help users understand how meal timing, eating patterns, and other behavioral factors relate to their individual metabolic responses—and ultimately support more personalized, preventive health interventions.

From Dental Replacement to Ingestion Intelligence™

DentalWig PLUS™ extends MYDENTALWIG’s vision beyond traditional dental replacement.

By integrating sensing technology into a dental platform, the Company aims to establish a new source of objective behavioral data: real-world ingestion activity.

Combined with physiological measurements, this data could support the development of personalized metabolic models, predictive health applications, and future digital health solutions.

The resulting EI²™ platform is intended to provide a foundation for applications extending beyond diabetes to broader metabolic health, including obesity management, metabolic syndrome, and other areas where eating behavior and physiological response intersect.

Built on a Defined Technology Development Roadmap

MYDENTALWIG’s development program is designed to advance DentalWig PLUS™ through measurable stages of technical feasibility, controlled ingestion testing, human pilot studies, CGM-integrated data collection, AI model development, clinical evaluation, and commercialization preparation.

The Company’s proposed 12-month development program is intended to establish the technical and scientific foundation for the product while advancing its engineering, manufacturing, regulatory, and commercial readiness.

Each stage is designed to address key technical and scientific questions, generate evidence, and support the next phase of development.

A New Opportunity for Investors

DentalWig PLUS™ – Diabetes is the first planned product in MYDENTALWIG’s broader Ingestion Intelligence™ strategy.

The Company’s vision is to transform ingestion from a largely unmeasured human behavior into a source of objective, analyzable data that can be connected with physiology through AI.

Through its proposed $21 million financing program, MYDENTALWIG intends to advance this vision through product engineering, sensor development, AI infrastructure, human validation, manufacturing preparation, and initial commercialization.

The long-term ambition is to build the missing sensory layer of human metabolism—connecting ingestion behavior with physiological intelligence to support the next generation of personalized and preventive healthcare.

DentalWig PLUS™ – Diabetes is under development. The sensing architecture, CGM integration, AI-powered metabolic predictions, and personalized feedback capabilities described above are development objectives that require appropriate technical and clinical validation. Product availability, pricing, features, and regulatory status are subject to development and applicable regulatory requirements.